About Us

Extraordinary minds.

Extraordinary science.

Ola Ola, heart and kidney transplant recipient, post-transplant lymphoproliferative disease (PTLD) advocate

Natural biology. Groundbreaking approach.

Atara's mission is to unleash the extraordinary power of the body's immune system. By harnessing the compelling biological features of T cells—the immune system's most effective weapon—we seek to deliver cell-based innovation in the form of next-generation allogeneic T-cell immunotherapies that aim to change patients' lives worldwide.

Our unique EBV T-cell platform sets us apart.

Our Epstein-Barr virus (EBV) T-cell platform uses allogeneic (donor-derived) T cells, next-generation CAR T technologies, and world-class manufacturing capabilities aimed at harnessing the power of the immune system to target and destroy disease-causing cells. Our platform is unique—αβ T cells that require no T-cell receptor or human leukocyte antigen gene editing—and it's what makes Atara well-positioned to deliver on our goal of bringing off-the-shelf immunotherapies to patients in need.

Learn More About Our Technology

Management team

Pascal Touchon

Pascal Touchon

President and Chief Executive Officer

Cokey Nguyen, Ph.D.

Cokey Nguyen, Ph.D.

Executive Vice President, Chief Scientific & Technical Officer

Eric Hyllengren

Eric Hyllengren

Executive Vice President, Chief Financial Officer

Jill Henrich

Jill Henrich

Executive Vice President, Global Head Regulatory Affairs & Quality

Rajani Dinavahi, M.D.

Rajani Dinavahi, M.D.

Senior Vice President, Chief Medical Officer

Dan Maziasz

Dan Maziasz

Executive Vice President, Chief Business Officer

K. Amar Murugan

K. Amar Murugan

Executive Vice President, Chief Legal Officer

Board of Directors

Carol G Gallagher, Pharm.D.

Carol G Gallagher, Pharm.D.

Chair of the Board

Eric Dobmeier

Eric Dobmeier

Director, Compensation Chair

Matthew Fust

Matthew Fust

Director, Audit Committee Chair

William Heiden

William Heiden

Director

Ameet Mallik

Ameet Mallik

Director, Nominating and Corporate Governance Chair

Maria Grazia Roncarolo, M.D.

Maria Grazia Roncarolo, M.D.

Director

Pascal Touchon

Pascal Touchon

President and Chief Executive Officer

We innovate with strategic partners.

As a pioneer of allogeneic T-cell immunotherapy, we're furthering our impact by collaborating with the world's leading academic institutions and companies to develop next-generation technologies.

Memorial Sloan Kettering Cancer Center

Memorial Sloan Kettering Cancer Center

In 2015, Atara entered into a license agreement with the Memorial Sloan Kettering Cancer Center for development, manufacturing, and more.

Pierre Fabre

Pierre Fabre

In 2021, Atara and Pierre Fabre entered a strategic collaboration to commercialize tab-cel® in Europe, Middle East, Africa, and other select markets.

Sustainable, ethical business practices.

We support environmental, social, and governance initiatives. Learn how we align our work with our mission, culture, and core values every day.